Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard, +547

European Journal of Cancer

Solid Cancer PatientsCancer EpidemiologyDisease Risk AssessmentMedicineEpidemiology Of Cancer +10

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

Xu-Shan Sun, Yungan Tao, Christophe Le Tourneau, +30

The Lancet Oncology

Radiation TherapyMedicineHigh-dose Cisplatin ChemoradiotherapyHead And Neck CancerDebio 1143 +7

Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Yungan Tao, Anne Aupérin, Xu-Shan Sun, +15

European Journal of Cancer

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy

Maciej Krzakowski, Rodryg Ramlau, Jacek Jassem, +15

Journal of Clinical Oncology

Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial

Yungan Tao, Xu-Shan Sun, Y. Pointreau, +29

European Journal of Cancer

Subcutaneous Interleukin-2 and Interferon Alfa Administration in Patients With Metastatic Renal Cell Carcinoma: Final Results of SCAPP III, a Large, Multicenter, Phase II, Nonrandomized Study With Sequential Analysis Design—The Subcutaneous Administration Propeukin Program Cooperative Group

Jean‐Marc Tourani, Christian Pfister, Mahmoud Ould-Kaci, +14

Journal of Clinical Oncology

Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

Yungan Tao, Anne Aupérin, Pierre Blanchard, +18

Radiotherapy and Oncology

Phase I/II and Pharmacokinetic Study of Intravenous Vinflunine in Combination With Cisplatin for the Treatment of Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer

Pierre-Jean Souquet, Maciej Krzakowski, Rodryg Ramlau, +6

Clinical Lung Cancer

Chemonaive PatientsMedicineIntravenous VinfluninePharmacologyMetronomic Therapy +5

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 “OMET” Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

Juliette Thariat, M. Bosset, Antoine Falcoz, +16

International Journal of Radiation Oncology*Biology*Physics

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis

S. Servagi Vernat, Jonathan Khalifa, Xu-Shan Sun, +9

Cancers